scientist using technology in the labInvesting in entrepreneurial research talent to pursue breakthrough science

The IBRI is dedicated to discovery with purpose—finding solutions to big problems—starting with solutions for patients suffering from cardiometabolic diseases that impact one-third of the global population. Metabolic diseases such as heart disease, diabetes and obesity, along with poor nutrition, are epidemics with significant health, quality of life and economic impacts.

The IBRI is led by a team of executives and support staff focused on building a research institute with eventually 150 to 200 scientists organized into research teams around eight to 12 Research Fellows who will be principal investigators.

These teams will partner with industry and academia on research projects and include experts from a spectrum of competencies, including bioengineering, bioinformatics, nanotechnology, agriculture and applied data science.

The IBRI is establishing state-of-the-art core research laboratories that focus on developing interventions, technologies, medicines and diagnostics to treat metabolic disease and improve nutrition.

2020 Annual Report cover

The IBRI 2020 Annual Report is now available. The report theme, ‘Shaping the Future of Translational Science,’ reflects the IBRI’s commitment to turning scientific discovery into improved outcomes for patients.